510(k) Report

510(k) · Cleared

Cleared

Olympus CK-MB Reagent

K070835510(k) TraditionalCleared Jun 4, 200769-day reviewClass II21 CFR 862.1215

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Olympus Life & Material Science Europa GmbH (Irish · JHY Colorimetric Method, Cpk Or Isoenzymes

Cleared on Jun 4, 2007 as substantially equivalent to K971817 (Olympus America, Inc., 1997) after a 69-day review. Its family tree reaches back 1 generation to 1997.

Decided
Jun 4, 2007
Review
69 days
Class
Class II
Product code
JHY
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K971817 (1997). No later device cites it as a predicate yet.

K971817 · Olympus CK-MB Reagent · Olympus America, Inc. · 19971996199820002002200420062008
K971817 · Olympus CK-MB Reagent · Olympus America, Inc. · 19970
  1. Root · 1 generation backK971817 Olympus CK-MB ReagentOlympus America, Inc. · 1997
  2. This deviceK070835 Olympus CK-MB ReagentOlympus Life & Material Science Europa GmbH (Irish · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K971817Olympus CK-MB ReagentOlympus America, Inc.1997—
0 (this device)K070835Olympus CK-MB ReagentOlympus Life & Material Science Europa GmbH (Irish2007—
FIG. 1 — Lineage of K070835, 1997–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JHY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K971817Olympus CK-MB Reagent
Summary page 1
…t system. 3. Predicate device Reagent: Olympus OSR6X53 CK-MB method Submitted (K971817) 4. Device description In this Olympus procedure: * The R1 reagent antibody binds…
Olympus America, Inc.1997—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All JHY devices

JHY Colorimetric Method, Cpk Or Isoenzymes: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · JHY

1in 2015

2007: 12013: 12014: 22015: 1
2007high 2 (2014) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JHY

Too few JHY 510(k)s in any year since 2007 to give a median.

Recalls per year · JHY

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JHY

3in 2023

2012: 12014: 32015: 22016: 42017: 112018: 52019: 22020: 22022: 12023: 3
2007high 11 (2017) · low 0 (2007)2025

MAUDE reports naming product code JHY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—00
20100—10
20110—00
20120—01
20131—00
20142—03
20151—02
20160—04
20170—011
20180—05
20190—02
20200—02
20210—00
20220—01
20230—03
20240—00
20250—00
20260—0—

What is it indicated for?

System reagent for the quantitative determination of Creatine Kinase-MB isoenzyme in human serum and heparinized plasma on OLYMPUS analyzers

Measurements of Creatine Kinase are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070835: Olympus CK-MB Reagent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K070835

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026